Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation

Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population

(2020) Wungrak Choi et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients

(2018) Wungrak Choi et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine

(2017) M. Elizabeth Fini et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Presence and Risk Factors for Glaucoma in Patients with Diabetes

(2016) Brian J. Song et al.   Current Diabetes Reports

INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY

(2016) Raj K. Maturi et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

(2014) David S. Boyer et al.   OPHTHALMOLOGY

Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior Uveitis

(2011) Careen Lowder   ARCHIVES OF OPHTHALMOLOGY

Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion

(2011) Julia A. Haller et al.   OPHTHALMOLOGY

Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion

(2010) Julia A. Haller et al.   OPHTHALMOLOGY

Risk Factors for Glaucoma Onset and Progression

(2008) Anne L. Coleman et al.   SURVEY OF OPHTHALMOLOGY